None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) Clinically definite liver cirrhosis patients or confirmed by liver biopsy (2) Patients who evaluate portal hypertension by hepatic vein pressure gradient (3) Patients who agree with enroll this study
Exclusion criteria
Exclusion criteria: (1) Baseline systolic blood pressure10mg/dL) (6) Serum creatinine = 1.2mg/dL (7) Past history of shunt procedure or TIPS (8) Administration of beta-blocker, ACE inhibitor, nitrate within 1month (9) Pregnancy (10) Patients who disagree with enroll this study (11) Patients who did not perform this study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The relationship between HAVT and HVPG | — |
Secondary
| Measure | Time frame |
|---|---|
| The mortality and variceal bleeding during 3years follow up;The variceal bleeding during 3years follow up | — |
Countries
Korea, Republic of
Contacts
Yonsei University, Wonju Severance Christian Hospital